Brought to you by 
Medicis to acquire Inamed for $2.76bn; offer withdrawn
15 Dec 2005
Executive Summary
Medicis (specialty pharmaceuticals for dermatological conditions) has agreed to acquire Inamed (breast implants, facial products, and devices for obesity) for $2.76bn, consisting of $1.08bn in cash and $1.68bn in stock.
Deal Industry
- Pharmaceuticals
-
Medical Devices
- Implantable Devices
Deal Status
- Withdrawn
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Medicis to acquire Inamed for $2.76bn; offer withdrawn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice